"The Digestive Health Center of Louisiana (DHCLA) was founded to promote and preserve the health of the Capitol Region. Completed in 2005, this state of the art building brings Gastroenterology Associates and Louisiana Endoscopy Center together under one roof, creating the most complete and comprehensive gastroenterology health center in the state. Whether you are a patient, potential patient, referring doctor, or human resources professional, we appreciate the opportunity to serve you."

During the past decade, Gastroenterology Associates, LLC conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 25 clinical trials were completed, i.e. on average, 75.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 16 clinical trials were completed. i.e. 320% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterology Associates, LLC" #1 sponsor was "Celgene" with 11 trials, followed by "Gilead Sciences" with 8 trials sponsored, "Takeda" with 5 trials sponsored, "Exact Sciences Corporation" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Associates, LLC" #1 collaborator was "Parexel" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates, LLC" are "Crohn's Disease" (9 trials), "Ulcerative Colitis" (9 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (4 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Gastroenterology Associates, LLC" in a lesser frequency.

Most popular intervention types in "Gastroenterology Associates, LLC" are "Drug" (46 trials), "Other" (9 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Etrolizumab" (3 trials), "GED-0301" (3 trials), "Ozanimod" (3 trials) and "RBV" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Associates, LLC" are 51 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gastroenterology Associates, LLC". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Gastroenterology Associates, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Associates, LLC, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".